These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35636090)

  • 1. Markedly asymmetric facial nerve hypertrophy simulating a schwannoma in a patient with Charcot-Marie-Tooth disease.
    Johnson BJ; Diehn FE; Nagelschneider AA; Tasche KK; Carlson ML
    Am J Otolaryngol; 2022; 43(4):103513. PubMed ID: 35636090
    [No Abstract]   [Full Text] [Related]  

  • 2. Charcot-Marie-Tooth disease: extensive cranial nerve involvement on CT and MR imaging.
    Aho TR; Wallace RC; Pitt AM; Sivakumar K
    AJNR Am J Neuroradiol; 2004 Mar; 25(3):494-7. PubMed ID: 15037479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charcot-Marie-Tooth 1A concurrent with schwannomas of the spinal cord and median nerve.
    Kwon JY; Chung KW; Park EK; Park SW; Choi BO
    J Korean Med Sci; 2009 Aug; 24(4):763-6. PubMed ID: 19654968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Painless cauda equina schwannoma simulating Charcot-Marie-Tooth disease.
    Roohi F; Cook AW; Clarke H; Torno R; Zandieh M
    J Neurol Neurosurg Psychiatry; 1982 Oct; 45(10):938. PubMed ID: 7143016
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurofibromatosis, Charcot-Marie-Tooth disease, or both?
    Roos KL; Pascuzzi RM; Dunn DW
    Neurofibromatosis; 1989; 2(4):238-43. PubMed ID: 2517818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P₂ phosphatase FIG4.
    Nicholson G; Lenk GM; Reddel SW; Grant AE; Towne CF; Ferguson CJ; Simpson E; Scheuerle A; Yasick M; Hoffman S; Blouin R; Brandt C; Coppola G; Biesecker LG; Batish SD; Meisler MH
    Brain; 2011 Jul; 134(Pt 7):1959-71. PubMed ID: 21705420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the MORC2 gene cause axonal Charcot-Marie-Tooth disease.
    Sevilla T; Lupo V; Martínez-Rubio D; Sancho P; Sivera R; Chumillas MJ; García-Romero M; Pascual-Pascual SI; Muelas N; Dopazo J; Vílchez JJ; Palau F; Espinós C
    Brain; 2016 Jan; 139(Pt 1):62-72. PubMed ID: 26497905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated Asymmetric Progressive Optic Neuropathy as a First Presentation of Charcot-Marie-Tooth Disease Type 2A.
    Gabel M; Mitchell J; Pramanik B; Geraci A; Harel A
    J Neuroophthalmol; 2021 Dec; 41(4):e699-e702. PubMed ID: 33110000
    [No Abstract]   [Full Text] [Related]  

  • 9. Trigeminal and facial nerve involvement in Charcot-Marie-Tooth disease. An electrodiagnostic study.
    Malin JP
    J Neurol; 1981; 226(2):101-9. PubMed ID: 6186779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurofibromatosis type 1 associated with Charcot-Marie-Tooth type 1A.
    Koc F; Guzel AI
    J Dermatol; 2009 May; 36(5):306-11. PubMed ID: 19383003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilateral oculomotor palsy in Charcot-Marie-Tooth disease 1A (CMT 1A).
    Posa A; Emmer A; Kornhuber ME
    Clin Neurol Neurosurg; 2017 Apr; 155():20-21. PubMed ID: 28214652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Charcot-Marie-Tooth disease associated with hip dysplasia: a case report.
    Cucuzzella TR; Guille JT; MacEwen GD
    Del Med J; 1996 Jun; 68(6):305-7. PubMed ID: 8698139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Charcot-Marie-Tooth disease in patients who have bilateral cavovarus feet.
    Nagai MK; Chan G; Guille JT; Kumar SJ; Scavina M; Mackenzie WG
    J Pediatr Orthop; 2006; 26(4):438-43. PubMed ID: 16791058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ataxia phenotype of type 1 Charcot-Marie-Tooth disease: an atypical presentation].
    Roubeau V; Guennoc AM; Praline J; Corcia P
    Rev Neurol (Paris); 2013 Jan; 169(1):93-4. PubMed ID: 22763203
    [No Abstract]   [Full Text] [Related]  

  • 15. Sonography of the median nerve in Charcot-Marie-Tooth disease.
    Martinoli C; Schenone A; Bianchi S; Mandich P; Caponetto C; Abbruzzese M; Derchi LE
    AJR Am J Roentgenol; 2002 Jun; 178(6):1553-6. PubMed ID: 12034637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding medication safety and Charcot-Marie-Tooth disease: a patient perspective.
    Socha Hernandez AV; Deeks LS; Shield AJ
    Int J Clin Pharm; 2020 Dec; 42(6):1507-1514. PubMed ID: 32804316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central nervous system signs in X-linked Charcot-Marie-Tooth disease after hyperventilation.
    Srinivasan J; Leventer RJ; Kornberg AJ; Dahl HH; Ryan MM
    Pediatr Neurol; 2008 Apr; 38(4):293-5. PubMed ID: 18358413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Charcot-Marie-Tooth disease associated with "essential tremor": Report of 7 cases and a review of the literature.
    Salisachs P
    J Neurol Sci; 1976 May; 28(1):17-40. PubMed ID: 932772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charcot-Marie-Tooth disease type 2C: a distinct genetic entity. Clinical and molecular characterization of the first European family.
    Santoro L; Manganelli F; Di Maio L; Barbieri F; Carella M; D'Adamo P; Casari G
    Neuromuscul Disord; 2002 May; 12(4):399-404. PubMed ID: 12062259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel mutation in FGD4 causes Charcot-Marie-Tooth disease type 4H with cranial nerve involvement.
    Kondo D; Shinoda K; Yamashita KI; Yamasaki R; Hashiguchi A; Takashima H; Kira JI
    Neuromuscul Disord; 2017 Oct; 27(10):959-961. PubMed ID: 28847448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.